Rational design of allosteric modulators: Challenges and successes

A Chatzigoulas, Z Cournia - Wiley Interdisciplinary Reviews …, 2021 - Wiley Online Library
Recent advances in structural biology and computational techniques have revealed
allosteric mechanisms for an abundance of targets leading to the establishment of rational …

A patent review on the current developments of benzoxazoles in drug discovery

XK Wong, KY Yeong - ChemMedChem, 2021 - Wiley Online Library
The benzoxazole moiety is widely found in various natural compounds, which are often
found to be biologically active. Due to its versatile biological properties, benzoxazole has …

A chemogenetic approach for dopamine imaging with tunable sensitivity

MA Labouesse, M Wilhelm, Z Kagiampaki… - Nature …, 2024 - nature.com
Genetically-encoded dopamine (DA) sensors enable high-resolution imaging of DA release,
but their ability to detect a wide range of extracellular DA levels, especially tonic versus …

Targeting GPCR signaling for idiopathic pulmonary fibrosis therapies

AJ Haak, MT Ducharme, AMD Espinosa… - Trends in …, 2020 - cell.com
A variety of G protein-coupled receptors (GPCRs) have been implicated in the pathogenesis
of pulmonary fibrosis, largely through their promotion of profibrotic fibroblast activation. By …

Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors

P Donthamsetti, N Winter, A Hoagland… - Nature …, 2021 - nature.com
Dopamine controls diverse behaviors and their dysregulation contributes to many disorders.
Our ability to understand and manipulate the function of dopamine is limited by the …

Novel Strategies To Activate the Dopamine D1 Receptor: Recent Advances in Orthosteric Agonism and Positive Allosteric Modulation

A Hall, L Provins, A Valade - Journal of medicinal chemistry, 2018 - ACS Publications
The five dopamine receptor subtypes (D1–5) are activated by the endogenous
catecholamine dopamine. Sustained research has sought to identify selective ligands for …

Synthesis and Pharmacological Characterization of 2-(2, 6-Dichlorophenyl)-1-((1 S, 3 R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3, 4 …

J Hao, JP Beck, JM Schaus, JH Krushinski, Q Chen… - 2019 - ACS Publications
Clinical development of catechol-based orthosteric agonists of the dopamine D1 receptor
has thus far been unsuccessful due to multiple challenges. To address these issues, we …

Allosteric Modulators of Dopamine D2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects …

AA Kaczor, TM Wróbel, D Bartuzi - Molecules, 2022 - mdpi.com
Allosteric modulation of G protein-coupled receptors (GPCRs) is nowadays a hot topic in
medicinal chemistry. Allosteric modulators, ie, compounds which bind in a receptor site …

Allosteric modulators of G protein-coupled dopamine and serotonin receptors: a new class of atypical antipsychotics

I Fasciani, F Petragnano, G Aloisi, F Marampon… - Pharmaceuticals, 2020 - mdpi.com
Schizophrenia was first described by Emil Krapelin in the 19th century as one of the major
mental illnesses causing disability worldwide. Since the introduction of chlorpromazine in …

Structure-based drug design for G protein-coupled receptors

M Congreve, JM Dias, FH Marshall - Progress in medicinal chemistry, 2014 - Elsevier
Our understanding of the structural biology of G protein-coupled receptors has undergone a
transformation over the past 5 years. New protein–ligand complexes are described almost …